JP2024541668A5 - - Google Patents

Info

Publication number
JP2024541668A5
JP2024541668A5 JP2024533063A JP2024533063A JP2024541668A5 JP 2024541668 A5 JP2024541668 A5 JP 2024541668A5 JP 2024533063 A JP2024533063 A JP 2024533063A JP 2024533063 A JP2024533063 A JP 2024533063A JP 2024541668 A5 JP2024541668 A5 JP 2024541668A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
amino acid
hcdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/136074 external-priority patent/WO2023098846A1/zh
Publication of JP2024541668A publication Critical patent/JP2024541668A/ja
Publication of JP2024541668A5 publication Critical patent/JP2024541668A5/ja
Pending legal-status Critical Current

Links

JP2024533063A 2021-12-03 2022-12-02 抗bcmaナノ抗体及びその応用 Pending JP2024541668A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111468274.X 2021-12-03
CN202111468274 2021-12-03
CN202211000054.9 2022-08-19
CN202211000054 2022-08-19
PCT/CN2022/136074 WO2023098846A1 (zh) 2021-12-03 2022-12-02 抗bcma纳米抗体及其应用

Publications (2)

Publication Number Publication Date
JP2024541668A JP2024541668A (ja) 2024-11-08
JP2024541668A5 true JP2024541668A5 (cg-RX-API-DMAC7.html) 2024-12-27

Family

ID=86611545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533063A Pending JP2024541668A (ja) 2021-12-03 2022-12-02 抗bcmaナノ抗体及びその応用

Country Status (5)

Country Link
US (1) US20250026844A1 (cg-RX-API-DMAC7.html)
EP (1) EP4428156A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024541668A (cg-RX-API-DMAC7.html)
CN (1) CN118696058A (cg-RX-API-DMAC7.html)
WO (1) WO2023098846A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117384287A (zh) * 2023-10-12 2024-01-12 浙江康佰裕生物科技有限公司 抗bcma单域抗体及其制备方法与应用
CN117534763B (zh) * 2023-12-28 2024-03-26 康维众和(中山)生物药业有限公司 抗bcma的纳米抗体及其制备方法与应用
WO2026072709A1 (en) 2024-09-25 2026-04-02 Orna Therapeutics, Inc. Chimeric antigen receptors targeting bcma
CN120329445B (zh) * 2025-06-20 2025-09-02 北京大学第一医院(北京大学第一临床医学院) 靶向bcma的单域抗体及其相关材料与应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
ATE374248T1 (de) 1996-06-27 2007-10-15 Vlaams Interuniv Inst Biotech Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
AU3596599A (en) 1998-01-26 1999-08-09 Unilever Plc Method for producing antibody fragments
BR9916765A (pt) 1999-01-05 2001-09-25 Unilever Nv Processo para produzir um material imunoadsorvente, uso de uma proteìna que é ligada por meio de uma ligação covalente a um fragmento de anticorpo, material imunadsorvente, uso de um material, e, kit de teste diagnóstico
ATE276359T1 (de) 1999-01-19 2004-10-15 Unilever Nv Verfahren zur herstellung von antikörperfragmenten
CN1252264C (zh) 1999-04-22 2006-04-19 荷兰联合利华有限公司 利用单价抗原-结合蛋白抑制病毒感染
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
ATE342922T1 (de) 1999-11-29 2006-11-15 Unilever Nv Immobilisierung von proteinen mit hilfe eines polypeptidsegments
ATE440111T1 (de) 1999-11-29 2009-09-15 Bac Ip B V Immobilisierte antigenbindende moleküle aus einer domäne
ATE428733T1 (de) 2000-03-14 2009-05-15 Unilever Nv Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen
US20030190598A1 (en) 2000-05-26 2003-10-09 Jasmid Tanha Single-domain antigen-binding antibody fragments derived from llama antibodies
AU2002229639A1 (en) 2000-12-13 2002-06-24 De Haard, Johannes Joseph Wilhelmus Camelidae antibody arrays
JP4213586B2 (ja) 2001-09-13 2009-01-21 株式会社抗体研究所 ラクダ抗体ライブラリーの作製方法
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
EP1456410A2 (en) 2001-12-11 2004-09-15 AlgoNomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
JP4323317B2 (ja) 2001-12-21 2009-09-02 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー) 可変領域配列のクローニング方法
WO2003055527A2 (en) 2002-01-03 2003-07-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Immunoconjugates useful for treatment of tumours
EP1558645B1 (en) 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
PT1687338E (pt) 2003-11-07 2011-01-20 Ablynx Nv Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
WO2006040153A2 (en) 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
JP2008528010A (ja) 2005-01-31 2008-07-31 アブリンクス ナームローゼ フェンノートシャップ 重鎖抗体の可変ドメイン配列を作出する方法
AU2006249144B2 (en) 2005-05-18 2011-11-17 Ablynx Nv Improved NanobodiesTM against Tumor Necrosis Factor-alpha
LT2444424T (lt) 2005-05-20 2018-10-25 Ablynx N.V. Pagerintos tm nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
TWI811023B (zh) * 2015-08-17 2023-08-01 美商健生生物科技公司 抗bcma抗體,結合bcma及cd3之雙特異性抗原結合分子及其用途
CA3078969A1 (en) 2017-10-13 2019-04-18 Harpoon Therapeutics, Inc. Trispecific proteins and methods of use
LT4324851T (lt) * 2018-07-19 2025-10-10 Chimeriniai antigeno receptoriai, pasižymintys bcma specifiškumu, ir jų panaudojimas
TWI838389B (zh) 2018-07-19 2024-04-11 美商再生元醫藥公司 雙特異性抗-BCMAx抗-CD3抗體及其用途
CN109134665B (zh) * 2018-08-24 2021-06-11 上海先博生物科技有限公司 一种基于单域抗体的bcma嵌合抗原受体及应用
BR112022001546A2 (pt) * 2019-07-30 2022-03-22 Jiangsu Hansoh Pharmaceutical Group Co Ltd Anticorpo anti-bcma, fragmento de ligação ao antígeno do mesmo e uso médico do mesmo
HUE068401T2 (hu) * 2019-11-11 2024-12-28 Amgen Res Munich Gmbh A BCMA elleni hatóanyagok adagolási rendje

Similar Documents

Publication Publication Date Title
US20230203201A1 (en) Binding molecules with modified j-chain
JP7058213B2 (ja) 改変j鎖を有する結合分子
Liu et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism
TWI874613B (zh) 微型導引和導航控制(miniGNC)類抗體蛋白及其製造和使用方法
US20210230269A1 (en) Immune-stimulating monoclonal antibodies against human interleukin-2
AU2019338602A1 (en) Anti-IL4 receptor antibodies for veterinary use
JP7596263B2 (ja) 4-1bb及び腫瘍関連抗原に結合する抗体構築物ならびにその使用
EP4403574A1 (en) Protein specifically binding to pd-1 and pharmaceutical use thereof
CN114262379B (zh) 一种pd-1/vegf四价双特异性抗体、其制备方法和用途
US20250051467A1 (en) Fap/cd40 binding molecule and medicinal use thereof
JP7851303B2 (ja) ヒトcd3イプシロンに結合する新規なヒト抗体
WO2021188631A1 (en) Anti-il4 receptor antibodies for veterinary use
WO2023246891A1 (zh) 结合egfr和b7-h3的双特异性抗体
US20220153832A1 (en) Anti-MARCO Antibodies and Uses Thereof
US20230265202A1 (en) Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof
JP7851924B2 (ja) 抗trop-2抗体、その抗原結合断片又はその変異体、及びそれらの医学的使用
US20230086069A1 (en) Anti-cd19 antibodies and methods of using and making thereof
WO2025207653A1 (en) Antibodies against lilrb4 and lilrb2 and uses thereof
KR20260047589A (ko) Btn3a 결합 단백질 및 이의 의학적 용도
AU2024237201A1 (en) Isolated bispecific antibody that specifically binds to cd3 and tumor antigen, and use thereof